{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:01:10Z","timestamp":1792454470866,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/ndt\/gfy024","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T12:10:55Z","timestamp":1516623055000},"page":"467-473","source":"Crossref","is-referenced-by-count":27,"title":["Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study"],"prefix":"10.1093","volume":"34","author":[{"given":"Desmond Y H","family":"Yap","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine P Y","family":"Kwan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie K M","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie M Y","family":"Mok","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary C W","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak Mao","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B1","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1093\/ndt\/gfs073","article-title":"Survival analysis and causes of mortality in patients with lupus nephritis","volume":"27","author":"Yap","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B2","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1681\/ASN.2010050472","article-title":"Updates on the treatment of lupus nephritis","volume":"21","author":"Bomback","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/ar3378","article-title":"Lupus nephritis: current update","volume":"13","author":"Saxena","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B5","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B6","first-page":"139","article-title":"KDIGO clinical practice guidelines for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nep.12136","article-title":"Overview of lupus nephritis management guidelines and perspective from Asia","volume":"19","author":"Mok","year":"2014","journal-title":"Nephrology"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.05040513","article-title":"Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis","volume":"9","author":"Parikh","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/03009749109165284","article-title":"Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determinations","volume":"20","author":"Gripenberg","year":"1991","journal-title":"Scand J Rheumatol"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/art.1780330505","article-title":"Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study","volume":"33","author":"ter Borg","year":"1990","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.1780390304","article-title":"Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail","volume":"39","author":"Esdaile","year":"1996","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0961203313515763","article-title":"A surge in anti-dsDNA titer predicts a severe lupus flare within six months","volume":"23","author":"Pan","year":"2014","journal-title":"Lupus"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-125-7-199610010-00003","article-title":"Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial","volume":"125","author":"Gourley","year":"1996","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/rheumatology\/kes293","article-title":"Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis","volume":"52","author":"Yap","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B16","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/art.22198","article-title":"The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial","volume":"54","author":"Tseng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B17","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(95)90114-0","article-title":"Prevention of relapses in systemic lupus erythematosus","volume":"345","author":"Bootsma","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B18","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B19","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B20","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0961203310388445","article-title":"International consensus for a definition of disease flare in lupus","volume":"20","author":"Ruperto","year":"2011","journal-title":"Lupus"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B22","doi-asserted-by":"crossref","DOI":"10.1002\/9780470773666","volume-title":"Statistical Methods in Medical Research","author":"Armitage","year":"2002"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0002-9343(87)90645-0","article-title":"Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization","volume":"83","author":"Appel","year":"1987","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3899\/jrheum.170226","article-title":"Longterm data on disease flares in patients with proliferative lupus nephritis in recent years","volume":"44","author":"Yap","year":"2017","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019030502561652800_gfy024-B25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O","article-title":"Damage in systemic lupus erythematosus and its association with corticosteroids","volume":"43","author":"Zonana-Nacach","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/3\/467\/27989236\/gfy024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T17:08:25Z","timestamp":1570640905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/3\/467\/4917682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,2]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy024","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,3,2]]}}}